<DOC>
	<DOCNO>NCT01741701</DOCNO>
	<brief_summary>The purpose study determine Oxaloacetate ( OAA ) safe effective treatment Parkinson 's disease . Each subject ask make 3 study visit complete two safety follow-up phone call 4 month period .</brief_summary>
	<brief_title>A Pilot Study Oxaloacetate Subjects With Treated PD</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Able give inform consent follow instruction per protocol Diagnosis idiopathic PD within 7 year diagnosis Taking stable dos levodopa would predictably need adjustment PD medication 4 month Unified Parkinson 's Disease Rating Scale ( UPDRS ) II + III least 30 point baseline Previously take Oxaloacetate Participation drug study use investigational product within 30 day prior baseline In Investigator 's opinion , unstable clinically significant condition would impair subject ' ability comply study followup Other know suspect cause parkinsonism</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>